CLINICAL AND PARA-CLINICAL FEATURES OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Huyền Nga Đỗ, Thị Thu Hường Nguyễn, Thanh Tùng Nguyễn

Main Article Content

Abstract

Objective: Describe clinical and para-clinical characteristics of primary CNS lymphoma; Research subjects and methods: Prospective Cross-sectional descriptive study conducted on 35 PCNSL patients treated at the Hematopoietic System Department of Hospital K from May 2019 to May 2022. Results: The average age of patients was 56.66 years; Men accounted for 54.3%; Typical clinical symptoms of primary CNS lymphoma are headache 77.1%, and hemiplegia 20%. Pathology results were diffuse large B-cell non-Hodgkin lymphoma 94.3%; activated B-cell type accounts for 74.3%; Typical Immune markers were CD20: 100%; Bcl6: 62.9%; MUM1: 62.9%; Bcl2: 11.4%, Ki67 average 78%. All patients had tumors located in the brain parenchyma. The proportion of patients with multiple brain tumors accounts for 74.3%. The highest incidence of tumors in the frontal lobe was 40%; The incidence of tumors in the occipital lobe was 25.7%; The incidence of tumors in the temporal lobe was 22.9%; The incidence of tumors in the parietal lobe was 20.0%; The incidence of tumors in the cerebellum was 11.4%. Conclusion: Primary CNS lymphoma is common in people over the age of 50, male gender, typical symptoms are headaches, may be accompanied by hemiplegia, the disease is usually large B-cell non-Hodgkin lymphoma, ABC type and often has lesions in the frontal and occipital lobes.

Article Details

References

1. El-Galaly TC et al. Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. European Journal of Cancer. 2018:57-68.
2. Louis BN et al. Primary CNS lymphoma. NCCN guidelines, version 32020. 2020:12-150.
3. Antonio Omuro. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015:1403-1410.
4. Nguyễn Trường Sơn. Bước đầu đánh giá hiệu quả phác đồ Methotrexate liều cao trong điều trị Lymphoma não nguyên phát tại Bệnh viện Chợ Rẫy năm 2008-2010. Y Học TP Hồ Chí Minh. 2011;15(2):14-19.
5. James L. Rubenstein. Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202). Journal of clinical oncology. 2013:3061-3073.
6. Barbara Jezersek Novakovic. Treatment outcomes and survival in patients with primary central nervous system lymphomas treated between 1995 and 2010 – a single centre report. Radiol Oncol. 2012;46(4):346-353.
7. Kuker W NT, Korfel A, et al.,. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005:169-177.